Inovio Pharmaceuticals (INO) Asset Utilization Ratio (2011 - 2025)
Inovio Pharmaceuticals' (INO) quarterly Asset Utilization Ratio came in at 0.0 in Q4 2025, down 54.0% year-over-year from 0.0 in Q4 2024, and down 65.68% quarter-over-quarter from 0.0 in Q3 2025.
Analysis
Inovio Pharmaceuticals (INO) Asset Utilization Ratio (2011 - 2025) Analysis & Trends
Inovio Pharmaceuticals has disclosed Asset Utilization Ratio across 15 years of filings, most recently posting 0.0 for Q4 2025.
- In Q4 2025, Asset Utilization Ratio fell 54.0% year-over-year to 0.0; the TTM figure through Dec 2025 stood at 0.0 (down 54.0% YoY), while the FY2025 annual figure was 0.0, down 54.53% from the prior year.
- Asset Utilization Ratio came in at 0.0 for Q4 2025 at Inovio Pharmaceuticals, down from 0.0 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.04 in Q2 2023 to a low of 0.0 in Q4 2025.
- Average Asset Utilization Ratio over 5 years is 0.01, with a median of 0.0 recorded in 2023.
- Year-over-year, Asset Utilization Ratio surged 871.97% in 2023 and slumped 88.31% in 2024.
- Over 5 years, Asset Utilization Ratio stood at 0.0 in 2021, then jumped by 705.63% to 0.03 in 2022, then tumbled by 83.51% to 0.0 in 2023, then tumbled by 56.74% to 0.0 in 2024, then sank by 54.0% to 0.0 in 2025.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.0 in Q4 2025, 0.0 in Q3 2025, and 0.0 in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 0.40 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 0.58 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 0.47 |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 0.38 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 0.20 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 0.90 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 0.33 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 0.00 |
| 10 | Inovio Pharmaceuticals | 104.88 Mn | 104.88 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.04 |
| Mar 31, 2023 | 0.03 |
| Dec 31, 2022 | 0.03 |
| Sep 30, 2022 | 0.03 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.00 |
| Sep 30, 2021 | 0.01 |
| Jun 30, 2021 | 0.01 |
| Mar 31, 2021 | 0.01 |